<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments for Healing Light Seminars</title>
	<atom:link href="http://www.healinglightseminars.com/comments/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.healinglightseminars.com</link>
	<description>Training and Resources for Clinical Excellence in Energetic Therapies</description>
	<lastBuildDate>Thu, 07 Jul 2011 23:01:21 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>Comment on Light therapy restores axonal transport in PD. by Neurological &#8211; Multiple Sclerosis, Parkinson&#8217;s Disease &#8211; Cooperative Medicine</title>
		<link>http://www.healinglightseminars.com/bioelectromagnetic-articles/light-therapy-restores-axonal-transport-in-pd/#comment-85</link>
		<dc:creator>Neurological &#8211; Multiple Sclerosis, Parkinson&#8217;s Disease &#8211; Cooperative Medicine</dc:creator>
		<pubDate>Thu, 07 Jul 2011 23:01:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=7734#comment-85</guid>
		<description>[...] Breakdown and impaired function of mitochondria resulting in insufficient ATP production has also been implicated in the pathogenesis of Parkinson’s disease.  Trimmer et al proposed that, as a result, axonal transport may be reduced in PD and also observed, “..that a single, brief treatment with near-infrared light can restore axonal transport to control levels. These results are the first demonstration that LLLT (low level laser therapy) can increase axonal transport in model human dopaminergic neuronal cells and they suggest that LLLT could be developed as a novel treatment to improve neuronal function in patients with PD.”  See the abstract in its entirety here. [...]</description>
		<content:encoded><![CDATA[<p>[...] Breakdown and impaired function of mitochondria resulting in insufficient ATP production has also been implicated in the pathogenesis of Parkinson’s disease.  Trimmer et al proposed that, as a result, axonal transport may be reduced in PD and also observed, “..that a single, brief treatment with near-infrared light can restore axonal transport to control levels. These results are the first demonstration that LLLT (low level laser therapy) can increase axonal transport in model human dopaminergic neuronal cells and they suggest that LLLT could be developed as a novel treatment to improve neuronal function in patients with PD.”  See the abstract in its entirety here. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Near-infrared light protects dopaminergic cells. by Neurological &#8211; Multiple Sclerosis, Parkinson&#8217;s Disease &#8211; Cooperative Medicine</title>
		<link>http://www.healinglightseminars.com/uncategorized/near-infrared-light-protects-dopaminergic-cells/#comment-84</link>
		<dc:creator>Neurological &#8211; Multiple Sclerosis, Parkinson&#8217;s Disease &#8211; Cooperative Medicine</dc:creator>
		<pubDate>Thu, 07 Jul 2011 23:00:05 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=7725#comment-84</guid>
		<description>[...] Signs and symptoms of Parkinson’s disease are associated with damage to the substantia nigra, cells at the base of the brain which produce the neurotransmitter, dopamine.  When Shaw et al administered near infrared light to dopaminergic cells from the substantia nigra, they found that it protected them from the effects of MPTP, a substance which induces Parkinson-like symptoms.  “In summary, our results indicate that NIR (near infrared) light treatment offers neuroprotection against MPTP toxicity for dopaminergic cells in the SNc (substantia nigra), but not in the ZI-Hyp (hypothalamus.”  Click here to view the full abstract. [...]</description>
		<content:encoded><![CDATA[<p>[...] Signs and symptoms of Parkinson’s disease are associated with damage to the substantia nigra, cells at the base of the brain which produce the neurotransmitter, dopamine.  When Shaw et al administered near infrared light to dopaminergic cells from the substantia nigra, they found that it protected them from the effects of MPTP, a substance which induces Parkinson-like symptoms.  “In summary, our results indicate that NIR (near infrared) light treatment offers neuroprotection against MPTP toxicity for dopaminergic cells in the SNc (substantia nigra), but not in the ZI-Hyp (hypothalamus.”  Click here to view the full abstract. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Multiple Sclerosis by Listening to Albert Einstein &#8211; Cooperative Medicine</title>
		<link>http://www.healinglightseminars.com/laser-research-library/multiple-sclerosis-2/#comment-83</link>
		<dc:creator>Listening to Albert Einstein &#8211; Cooperative Medicine</dc:creator>
		<pubDate>Thu, 07 Jul 2011 21:46:33 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=6866#comment-83</guid>
		<description>[...] Multiple Sclerosis [...]</description>
		<content:encoded><![CDATA[<p>[...] Multiple Sclerosis [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Light therapy restores axonal transport in PD. by Listening to Albert Einstein &#8211; Cooperative Medicine</title>
		<link>http://www.healinglightseminars.com/bioelectromagnetic-articles/light-therapy-restores-axonal-transport-in-pd/#comment-82</link>
		<dc:creator>Listening to Albert Einstein &#8211; Cooperative Medicine</dc:creator>
		<pubDate>Thu, 07 Jul 2011 21:44:21 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=7734#comment-82</guid>
		<description>[...] LLLT could be developed as a novel treatment to improve neuronal function in patients with PD.” See the abstract in its entirety here. [...]</description>
		<content:encoded><![CDATA[<p>[...] LLLT could be developed as a novel treatment to improve neuronal function in patients with PD.” See the abstract in its entirety here. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Peripheral Nerve Regeneration by Listening to Albert Einstein &#8211; Cooperative Medicine</title>
		<link>http://www.healinglightseminars.com/laser-research-library/peripheral-nerve-regeneration/#comment-81</link>
		<dc:creator>Listening to Albert Einstein &#8211; Cooperative Medicine</dc:creator>
		<pubDate>Thu, 07 Jul 2011 21:37:39 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=6829#comment-81</guid>
		<description>[...] Peripheral Nerve Regeneration [...]</description>
		<content:encoded><![CDATA[<p>[...] Peripheral Nerve Regeneration [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Central Nervous System Disorders by Listening to Albert Einstein &#8211; Cooperative Medicine</title>
		<link>http://www.healinglightseminars.com/laser-research-library/cns-injury-spinal-cord-brain-2/#comment-80</link>
		<dc:creator>Listening to Albert Einstein &#8211; Cooperative Medicine</dc:creator>
		<pubDate>Thu, 07 Jul 2011 21:37:19 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=6984#comment-80</guid>
		<description>[...] Central Nervous System Disorders [...]</description>
		<content:encoded><![CDATA[<p>[...] Central Nervous System Disorders [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Near-infrared light protects dopaminergic cells. by Listening to Albert Einstein &#8211; Cooperative Medicine</title>
		<link>http://www.healinglightseminars.com/uncategorized/near-infrared-light-protects-dopaminergic-cells/#comment-79</link>
		<dc:creator>Listening to Albert Einstein &#8211; Cooperative Medicine</dc:creator>
		<pubDate>Thu, 07 Jul 2011 21:37:01 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=7725#comment-79</guid>
		<description>[...] for dopaminergic cells in the SNc (substantia nigra), but not in the ZI-Hyp (hypothalamus).” Click here to view the full abstract. [...]</description>
		<content:encoded><![CDATA[<p>[...] for dopaminergic cells in the SNc (substantia nigra), but not in the ZI-Hyp (hypothalamus).” Click here to view the full abstract. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Listening to Albert Einstein by Listening to Albert Einstein &#8211; Cooperative Medicine</title>
		<link>http://www.healinglightseminars.com/uncategorized/7906/#comment-78</link>
		<dc:creator>Listening to Albert Einstein &#8211; Cooperative Medicine</dc:creator>
		<pubDate>Thu, 07 Jul 2011 21:36:44 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=7906#comment-78</guid>
		<description>[...] Listening to Albert Einstein   Albert Einstein defined insanity as doing the same thing over and over again and expecting different results.  For the last 30 years, management of acute spinal cord injuries has usually included high dosages of the steroid methylprednisolone.  Perhaps the rationale for this treatment was based more on the theory of how corticosteroids were supposed to work than the reality.  In a 2006 survey of spine surgeons linked here, only 24% reported that they believed that methylprednisolone had any clinical value in spinal cord injury, yet 90.5% indicated that they continued to administer this treatment protocol.  [1] [...]</description>
		<content:encoded><![CDATA[<p>[...] Listening to Albert Einstein   Albert Einstein defined insanity as doing the same thing over and over again and expecting different results.  For the last 30 years, management of acute spinal cord injuries has usually included high dosages of the steroid methylprednisolone.  Perhaps the rationale for this treatment was based more on the theory of how corticosteroids were supposed to work than the reality.  In a 2006 survey of spine surgeons linked here, only 24% reported that they believed that methylprednisolone had any clinical value in spinal cord injury, yet 90.5% indicated that they continued to administer this treatment protocol.  [1] [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Light therapy restores axonal transport in PD. by Listening to Albert Einstein &#8211; Healing Light Seminars</title>
		<link>http://www.healinglightseminars.com/bioelectromagnetic-articles/light-therapy-restores-axonal-transport-in-pd/#comment-77</link>
		<dc:creator>Listening to Albert Einstein &#8211; Healing Light Seminars</dc:creator>
		<pubDate>Thu, 07 Jul 2011 18:22:09 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=7734#comment-77</guid>
		<description>[...] Light therapy restores axonal transport in PD. [...]</description>
		<content:encoded><![CDATA[<p>[...] Light therapy restores axonal transport in PD. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>Comment on Near-infrared light protects dopaminergic cells. by Healing Light Seminars</title>
		<link>http://www.healinglightseminars.com/uncategorized/near-infrared-light-protects-dopaminergic-cells/#comment-76</link>
		<dc:creator>Healing Light Seminars</dc:creator>
		<pubDate>Thu, 07 Jul 2011 18:18:27 +0000</pubDate>
		<guid isPermaLink="false">http://www.healinglightseminars.com/?p=7725#comment-76</guid>
		<description>[...] Near-infrared light protects dopaminergic cells. [...]</description>
		<content:encoded><![CDATA[<p>[...] Near-infrared light protects dopaminergic cells. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

